Close

Analyst Ratings for Corcept Therapeutics (CORT) [Sells]

CORT Rating Summary

CORT Price Target Summary

* Over Last 12-Mos
  |   Expand Research on CORT
Overall Rating: NEUTRAL   Rating Trend: Down   Avg. $ Target: $35.50 (+42.1%) * Over Last 12-Mos
Rating Score: 5.3 / 10   Percentile Rank: 55%
Date Firm Analyst Type Rating
(Past)
PT
(Past)
Start $
(End $)
% Chg. Details
12/20/2016 Janney N/A New Coverage Sell
(N/A)
7.00
(N/A)
8.47
(24.98)
194.92% Details
7/13/2012 BofA Securities
» Updated 7/6/2018
N/A New Coverage Underperform
(N/A)
6.00
(N/A)
4.44
(24.98)
462.61% Details
Like CORT Ratings? Also take a look at MFIN, AGFY, RBB, CDNA

CORT Ratings News